Comparison of emergence after deep extubation using desflurane or desflurane with remifentanil in patients undergoing general anesthesia: a randomized trial

Journal of Clinical Anesthesia
Min Kyong KimYoung Cheol Woo

Abstract

To compare recovery times and respiratory complications during emergence after deep extubation using either desflurane alone or a lower concentration of desflurane with remifentanil. Prospective randomized double-blind clinical trial. Intraoperative. A total of 62 patients between the ages of 20 and 60 years with American Society of Anesthesiologists class I or II and who underwent low- to intermediate-risk surgery of 2- to 4-hour duration were enrolled. Randomly assigned either 1.5 minimum alveolar concentration desflurane (group D; n = 31) or 1.0 minimum alveolar concentration of desflurane and 1.0 ng/mL effect-site concentration of remifentanil (group DR; n = 31). Recovery times, from the time of extubation to the time when the patients could breathe without assistance, were awake enough to maintain the airway independently, and exited the recovery room, as well as respiratory complications were compared between the groups. Recovery times were significantly reduced in the group DR (P < .001). The incidence of respiratory complications was also lower in group DR than in group D (48% vs 3.8%; P < .001). The combined use of remifentanil while lowering the concentration of desflurane improves recovery profiles during emergence a...Continue Reading

References

Jul 1, 1985·Canadian Anaesthetists' Society Journal·S R MallampatiP L Liu
Jan 1, 1995·Anesthesia and Analgesia·K A MillerP L Bailey
Apr 1, 1994·Anesthesiology·E I Eger
Dec 13, 2002·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Franco CavaliereRodolfo Proietti
Sep 1, 2005·Anesthesiology·Shahbaz R ArainThomas J Ebert
Oct 24, 2006·Anesthesia and Analgesia·Rachel Eshima McKayWarren R McKay
Mar 21, 2009·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Christian GodballeTroels Nielsen
Jul 1, 2009·Clinical and Experimental Otorhinolaryngology·Hyoung Shin LeeKang Dae Lee

❮ Previous
Next ❯

Citations

Mar 4, 2018·Aging Clinical and Experimental Research·Masanori TsukamotoTakeshi Yokoyama
Jul 6, 2019·Clinical Oral Investigations·Masanori TsukamotoTakeshi Yokoyama
Jan 30, 2021·Anesthesiology Research and Practice·Tiffany H WongApolonia E Abramowicz
Oct 31, 2020·BMC Anesthesiology·Jeremy JuangAlvaro Andres Macias
Aug 25, 2018·Journal of Clinical Anesthesia·Gildasio S De Oliveira

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.